InspireMD
NSPR
15 hedge funds and large institutions have $272K invested in InspireMD in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
300% more capital invested
Capital invested by funds: $68K → $272K (+$204K)
88% more funds holding
Funds holding: 8 → 15 (+7)
0.09% more ownership
Funds ownership: 0.16% → 0.25% (+0.09%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$55.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$35.2K |
| 3 |
Renaissance Technologies
New York
|
+$25.8K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$25.2K |
| 5 |
Two Sigma Investments
New York
|
+$23.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$18K |
| 2 |
CP
Corbenic Partners
Bethlehem,
Pennsylvania
|
-$3K |
NSPR Hedge Fund Activity: Q2 2020 in Review
15 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2020, worth a combined $272K — up 300% from $68K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new NSPR positions and 2 closed out — a net gain of 7 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Wedbush Securities, adding an estimated $55.4K. The largest seller was Barclays, exiting entirely with an estimated $18K sold.
- 15 institutional investors held InspireMD (NSPR) as of Q2 2020, up from 8 in Q1 2020.
- Funds reported $272K of InspireMD stock for Q2 2020, up 300% quarter-over-quarter.
- 9 funds opened new InspireMD positions in Q2 2020 and 2 closed out, a net change of +7 holders.
- The largest InspireMD buyer in Q2 2020 was Wedbush Securities, an estimated $55.4K added.
- The largest InspireMD seller in Q2 2020 was Barclays, an estimated $18K sold.
Based on aggregated 13F filings for Q2 2020.